$96.1 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 24 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TXN | TEXAS INSTRUMENTS INC | $4,569,000 | +12.5% | 32,000 | 0.0% | 4.76% | -69.7% | |
SOLY | SOLITON INC | $3,247,000 | -1.8% | 425,000 | 0.0% | 3.38% | -73.6% | |
AGLE | AEGLEA BIOTHERAPEUTICS INC | $1,983,000 | -23.3% | 279,678 | 0.0% | 2.06% | -79.4% | |
APEN | APOLLO ENDOSURGERY INC | $472,000 | +3.5% | 279,037 | 0.0% | 0.49% | -72.1% | |
PLXP | PLX PHARMA INC | $202,000 | -0.5% | 62,673 | 0.0% | 0.21% | -73.2% | |
LXRX | LEXICON PHARMACEUTICALS INC | $51,000 | -28.2% | 35,714 | 0.0% | 0.05% | -80.7% | |
POR | PORTLAND GENERAL ELECTRIC CO | $4,000 | -20.0% | 118 | 0.0% | 0.00% | -78.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-05-01 |
3 | 2024-04-30 |
13F-HR | 2024-04-30 |
144 | 2024-04-29 |
SC 13G | 2024-03-05 |
13F-HR | 2024-02-28 |
SC 13G | 2024-02-14 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-04 |
3 | 2023-06-02 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.